Drug intelligence / Profile preview

LAG-3 PROTAC-1

Development stage
Unknown
Lead developer
Weill Cornell Medicine
Modality
PROTACs (E3 ligase recruitment) → Targeted Protein Degraders (TPDs) → Small Molecules
01

Overview

LAG-3 PROTAC-1: sourced facts only. name: "Western blot analysis in Raji-LAG3 cells demonstrated that LAG-3 PROTAC-1 and LAG-3 PROTAC-3 induce potent, dose-dependent degradation of LAG-3, with DC50 values of 0.27 μM and 0.42 μM, respectively." [PMID:41052608]; target: "Western blot analysis in Raji-LAG3 cells demonstrated that LAG-3 PROTAC-1 and LAG-3 PROTAC-3 induce potent, dose-dependent degradation of LAG-3, with DC50 values of 0.27 μM and 0.42 μM, respectively." [PMID:41052608]; developer: "Department of Radiology, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, New York, NY 10065, USA." [PMID:41052608]; modality: "Here, we report the design and validation of the first-in-class PROTACs for targeted degradation of LAG-3." [PMID:41052608]

02

Targets

LAG3 (Lymphocyte activation Gene-3 protein)

Beyond the preview

Go deeper on LAG-3 PROTAC-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LAG-3 PROTAC-1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call